查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1869707

生物製藥低溫運輸第三方物流市場規模、佔有率和趨勢分析報告：按服務、溫度範圍、地區和細分市場預測（2025-2033 年）

Biopharmaceutical Cold Chain Third Party Logistics Market Size, Share & Trends Analysis Report By Services, By Temperature Range, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

生物製藥低溫運輸第三方物流市場摘要

2024年全球生物製藥低溫運輸第三方物流市場規模估計為305.9億美元，預計2033年將達到744.6億美元。

預計從 2025 年到 2033 年，該市場將以 10.54% 的複合年成長率成長。這一市場成長是由於對溫控藥品的需求不斷增加、藥品儲存和運輸的監管要求日益嚴格，以及生物製藥和疫苗的全球分銷範圍擴大。

此外，製藥公司物流服務外包的日益增加也推動了市場的進一步擴張。同時，生物製藥、疫苗和溫敏藥物需求的不斷成長，也顯著提升了對可靠低溫運輸物流解決方案的需求。單株抗體、基因療法和重組蛋白等生物製藥需要嚴格的溫度控制，通常在2 度C至8 度C之間，以維持其療效，有些甚至需要在-70 度C以下的超低溫環境下儲存。

此外，個人化醫療的日益普及進一步增加了對專業物流解決方案的需求，以確保產品在整個供應鏈中的完整性。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 技術格局
  • 定價模式分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL 分析
    • 新冠疫情影響分析

第4章 生物製藥低溫運輸第三方物流市場：服務預測與趨勢分析

  • 細分儀表板
  • 生物製藥低溫運輸第三方物流市場：服務差異分析
  • 2021-2033年生物製藥低溫運輸第三方物流規模及服務趨勢分析
  • 運輸
    • 空運
    • 海運
    • 陸上
  • 倉庫/存儲
  • 包裝解決方案
  • 監控和視覺化解決方案
  • 庫存管理
  • 其他

第5章 生物製藥低溫運輸第三方物流市場：溫度範圍估算與趨勢分析

  • 細分儀表板
  • 生物製藥低溫運輸第三方物流市場：溫度範圍變化分析
  • 2021-2033年生物製藥低溫運輸第三方物流規模及趨勢分析（依溫度範圍分類）
  • 冷凍
    • 超速冷凍/快速冷凍
    • 低溫

第6章 區域業務分析

  • 區域儀錶板
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 2021-2033年北美生物製藥低溫運輸第三方物流市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2021-2033年歐洲生物製藥低溫運輸第三方物流市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2021-2033年亞太地區生物製藥低溫運輸第三方物流市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2021-2033年拉丁美洲生物製藥低溫運輸第三方物流市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2021-2033年中東及非洲生物製藥低溫運輸第三方物流市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 阿曼
    • 卡達

第7章 競爭情勢

  • 公司分類
  • 企業市場分析，2024年
  • 公司簡介
    • Cardinal Health
    • DHL Group
    • Agility
    • SF Express
    • Kinesis Medical BV
    • United Parcel Service of America, Inc.
    • Barrett Distribution
    • Cencora
    • DB Schenker
    • FedEx
    • KUEHNE+NAGEL
    • Kerry Logistics Network Ltd
    • Freight Logistics Solutions
Product Code: GVR-4-68040-766-9

Biopharmaceutical Cold Chain Third Party Logistics Market Summary

The global biopharmaceutical cold chain third party logistics market size was estimated at USD 30.59 billion in 2024 and is projected to reach USD 74.46 billion by 2033, growing at a CAGR of 10.54% from 2025 to 2033. This market growth is due to the rising demand for temperature-sensitive pharmaceuticals, stringent drug storage and transportation regulatory requirements, and the global expansion of biologics and vaccine distribution.

In addition, increasing outsourcing of logistics services by pharmaceutical companies is further driving market expansion. Furthermore, increasing demand for biologics, vaccines, and temperature-sensitive drugs has significantly expanded the need for reliable cold chain logistics solutions. Biologics, including monoclonal antibodies, gene therapies, and recombinant proteins, require stringent temperature control, typically between 2°C and 8°C, with some requiring ultra-low storage at -70°C or lower-to maintain their efficacy.

Moreover, the growing trend towards personalized medicine has further boosted the need for specialized logistics solutions to ensure product integrity throughout the supply chain.

Global Biopharmaceutical Cold Chain Third Party Logistics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global biopharmaceutical cold chain third party logistics market based on service, temperature range, and region:

  • Services Outlook (Revenue, USD Million, 2021 - 2033)
  • Transportation
    • Air Freight
    • Sea Freight
    • Overland
  • Warehousing & Storage
  • Packaging Solutions
  • Monitoring & Visibility Solutions
  • Inventory Management
  • Others
  • Temperature Range Outlook (Revenue, USD Million, 2021 - 2033)
  • Frozen
  • Ultra-frozen/Deep-Frozen
  • Cryogenic
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Oman
    • Qatar

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Analysis
    • 1.3.1. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Technological Landscape
  • 3.5. Pricing Model Analysis
  • 3.6. Industry Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Biopharmaceutical Cold Chain Third Party Logistics Market: Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biopharmaceutical Cold Chain Third Party Logistics Market: Service Movement Analysis
  • 4.3. Biopharmaceutical Cold Chain Third Party Logistics Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
  • 4.4. Transportation
    • 4.4.1. Transportation market estimates and forecasts 2021 - 2033 (USD Million)
    • 4.4.2. Air Freight
      • 4.4.2.1. Air Freight market estimates and forecasts 2021 - 2033 (USD Million)
    • 4.4.3. Sea Freight
      • 4.4.3.1. Sea Freight market estimates and forecasts 2021 - 2033 (USD Million)
    • 4.4.4. Overland
      • 4.4.4.1. Overland market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.5. Warehousing & Storage
    • 4.5.1. Warehousing & Storage market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.6. Packaging Solutions
    • 4.6.1. Packaging Solutions market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.7. Monitoring & Visibility Solutions
    • 4.7.1. Monitoring & Visibility Solutions market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.8. Inventory Management
    • 4.8.1. Inventory Management market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 5. Biopharmaceutical Cold Chain Third Party Logistics Market: Temperature Range Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biopharmaceutical Cold Chain Third Party Logistics Market: Temperature Range Movement Analysis
  • 5.3. Biopharmaceutical Cold Chain Third Party Logistics Size & Trend Analysis, by Temperature Range, 2021 to 2033 (USD Million)
  • 5.4. Frozen
    • 5.4.1. Frozen market estimates and forecasts 2021 - 2033 (USD Million)
    • 5.4.2. Ultra-frozen/Deep-Frozen
      • 5.4.2.1. Ultra-frozen/Deep-Frozen market estimates and forecasts 2021 - 2033 (USD Million)
    • 5.4.3. Cryogenic
      • 5.4.3.1. Cryogenic market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 6.3. North America
    • 6.3.1. North America Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. U.S. Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Canada Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Mexico Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Germany Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.4.3. UK
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. UK Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. France Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Italy Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Spain Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Denmark Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Framework
      • 6.4.8.4. Sweden Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Regulatory Framework
      • 6.4.9.4. Norway Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Japan Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. China Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. India Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. South Korea Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.5.6. Australia
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Australia Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.5.7. Thailand
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Thailand Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Brazil Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Argentina Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. South Africa Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Saudi Arabia Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. UAE Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Kuwait Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.7.6. Oman
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory Framework
      • 6.7.6.4. Oman Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)
    • 6.7.7. Qatar
      • 6.7.7.1. Key Country Dynamics
      • 6.7.7.2. Competitive Scenario
      • 6.7.7.3. Regulatory Framework
      • 6.7.7.4. Qatar Biopharmaceutical Cold Chain Third Party Logistics market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Company Market Position Analysis, 2024
  • 7.3. Company Profiles
    • 7.3.1. Cardinal Health
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Service benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. DHL Group
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Service benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Agility
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Service benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. SF Express
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Service benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Kinesis Medical B.V.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Service benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. United Parcel Service of America, Inc.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Service benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Barrett Distribution
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Service benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Cencora
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Service benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. DB Schenker
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Service benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. FedEx
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Service benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. KUEHNE + NAGEL
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Service benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Kerry Logistics Network Ltd
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Service benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Freight Logistics Solutions
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Service benchmarking
      • 7.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 4 Global Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 5 Global Biopharmaceutical Cold Chain Third Party Logistics Market, by Region, 2021 - 2033 (USD Million)
  • Table 6 North America Biopharmaceutical Cold Chain Third Party Logistics Market, by Country, 2021 - 2033 (USD Million)
  • Table 7 North America Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 8 North America Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 9 U.S. Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 10 U.S. Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 11 Canada Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 12 Canada Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 13 Mexico Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 14 Mexico Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 15 Europe Biopharmaceutical Cold Chain Third Party Logistics Market, by Country, 2021 - 2033 (USD Million)
  • Table 16 Europe Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 17 Europe Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 18 UK Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 19 UK Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 20 Germany Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 21 Germany Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 22 France Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 23 France Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 24 Italy Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 25 Italy Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 26 Spain Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 27 Spain Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 28 Denmark Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 29 Denmark Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 30 Sweden Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 31 Sweden Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 32 Norway Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 33 Norway Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific Biopharmaceutical Cold Chain Third Party Logistics Market, by Country, 2021 - 2033 (USD Million)
  • Table 35 Asia Pacific Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 36 Asia Pacific Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 37 Japan Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 38 Japan Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 39 China Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 40 China Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 41 India Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 42 India Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 43 Australia Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 44 Australia Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 45 South Korea Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 46 South Korea Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 47 Thailand Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 48 Thailand Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 49 Latin America Biopharmaceutical Cold Chain Third Party Logistics Market, by Country, 2021 - 2033 (USD Million)
  • Table 50 Latin America Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 51 Latin America Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 52 Brazil Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 53 Brazil Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 54 Argentina Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 55 Argentina Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 56 MEA Biopharmaceutical Cold Chain Third Party Logistics Market, by Country, 2021 - 2033 (USD Million)
  • Table 57 MEA Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 58 MEA Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 59 South Africa Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 60 South Africa Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 61 Saudi Arabia Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 62 Saudi Arabia Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 63 UAE Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 64 UAE Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 65 Kuwait Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 66 Kuwait Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 67 Oman Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 68 Oman Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)
  • Table 69 Qatar Biopharmaceutical Cold Chain Third Party Logistics Market, by Service, 2021 - 2033 (USD Million)
  • Table 70 Qatar Biopharmaceutical Cold Chain Third Party Logistics Market, by Temperature Range, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Biopharmaceutical Cold Chain Third Party Logistics Market Segmentation
  • Fig. 7 Market Snapshot, 2024
  • Fig. 8 Market Trends & Outlook
  • Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Global Biopharmaceutical Cold Chain Third Party Logistics Market: Service Key Takeaways
  • Fig. 14 Global Biopharmaceutical Cold Chain Third Party Logistics Market: Service Movement Analysis
  • Fig. 15 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Transportation, 2021 - 2033 (USD Million)
  • Fig. 16 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Air Freight, 2021 - 2033 (USD Million)
  • Fig. 17 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Sea Freight, 2021 - 2033 (USD Million)
  • Fig. 18 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Overland, 2021 - 2033 (USD Million)
  • Fig. 19 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Warehousing & Storage, 2021 - 2033 (USD Million)
  • Fig. 20 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Packaging Solutions, 2021 - 2033 (USD Million)
  • Fig. 21 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Monitoring & Visibility Solutions, 2021 - 2033 (USD Million)
  • Fig. 22 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Inventory Management, 2021 - 2033 (USD Million)
  • Fig. 23 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 24 Global Biopharmaceutical Cold Chain Third Party Logistics Market: Temperature Range Key Takeaways
  • Fig. 25 Global Biopharmaceutical Cold Chain Third Party Logistics Market, Temperature Range Movement Analysis
  • Fig. 26 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Frozen, 2021 - 2033 (USD Million)
  • Fig. 27 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Ultra-frozen/Deep-Frozen, 2021 - 2033 (USD Million)
  • Fig. 28 Global Biopharmaceutical Cold Chain Third Party Logistics Market, for Cryogenic, 2021 - 2033 (USD Million)
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional Outlook, 2024 & 2033
  • Fig. 31 North America Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 33 Canada Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 34 Mexico Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 35 Europe Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 36 Germany Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 37 UK Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 38 France Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 39 Italy Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 40 Spain Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 41 Denmark Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 42 Sweden Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 43 Norway Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 44 Asia Pacific Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 45 Japan Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 46 China Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 47 India Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 48 Australia Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 49 South Korea Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 50 Thailand Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 51 Latin America Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 52 Brazil Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 53 Argentina Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 54 Middle East and Africa Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 55 South Africa Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 56 Saudi Arabia Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 57 UAE Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 58 Kuwait Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 59 Oman Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)
  • Fig. 60 Qatar Biopharmaceutical Cold Chain Third Party Logistics Market, 2021 - 2033 (USD Million)